{"id":"https://openalex.org/W4385686241","doi":"https://doi.org/10.4049/jimmunol.210.supp.230.11","title":"Hijacking Suppression: Anti-CD40 Converts Regulatory T Cells Into Type I Effectors","display_name":"Hijacking Suppression: Anti-CD40 Converts Regulatory T Cells Into Type I Effectors","publication_year":2023,"publication_date":"2023-05-01","ids":{"openalex":"https://openalex.org/W4385686241","doi":"https://doi.org/10.4049/jimmunol.210.supp.230.11"},"language":"en","primary_location":{"id":"doi:10.4049/jimmunol.210.supp.230.11","doi":"https://doi.org/10.4049/jimmunol.210.supp.230.11","is_oa":true,"landing_page_url":"https://doi.org/10.4049/jimmunol.210.supp.230.11","pdf_url":"https://journals.aai.org/jimmunol/article-pdf/210/1_Supplement/230.11/1631010/230_11.pdf","source":{"id":"https://openalex.org/S38008053","display_name":"The Journal of Immunology","issn_l":"0022-1767","issn":["0022-1767","1550-6606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4320800377","host_organization_name":"American Association of Immunologists","host_organization_lineage":["https://openalex.org/P4320800377"],"host_organization_lineage_names":["American Association of Immunologists"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Immunology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://journals.aai.org/jimmunol/article-pdf/210/1_Supplement/230.11/1631010/230_11.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5008775427","display_name":"Vivien Ileana Maltez","orcid":"https://orcid.org/0000-0003-2330-7518","observed_orcids":["https://orcid.org/0000-0003-2330-7518"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210134534","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210134534"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vivien Ileana Maltez","raw_affiliation_strings":["NIAID, NIH","1NIAID, NIH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NIAID, NIH","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210134534"]},{"raw_affiliation_string":"1NIAID, NIH","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210134534"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017801512","display_name":"Charu Arora","orcid":"https://orcid.org/0009-0006-6510-6975","observed_orcids":["https://orcid.org/0009-0006-6510-6975"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Charu Arora","raw_affiliation_strings":["Perelman Sch. of Med., Univ. of Pennsylvania","2Perelman Sch. of Med., Univ. of Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Perelman Sch. of Med., Univ. of Pennsylvania","institution_ids":["https://openalex.org/I79576946"]},{"raw_affiliation_string":"2Perelman Sch. of Med., Univ. of Pennsylvania","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080637780","display_name":"Rina Sor","orcid":"https://orcid.org/0000-0003-2042-5746","observed_orcids":["https://orcid.org/0000-0003-2042-5746"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rina Sor","raw_affiliation_strings":["Perelman Sch. of Med., Univ. of Pennsylvania","2Perelman Sch. of Med., Univ. of Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Perelman Sch. of Med., Univ. of Pennsylvania","institution_ids":["https://openalex.org/I79576946"]},{"raw_affiliation_string":"2Perelman Sch. of Med., Univ. of Pennsylvania","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078325244","display_name":"Qiaoshi Lian","orcid":"https://orcid.org/0000-0002-3628-9390","observed_orcids":["https://orcid.org/0000-0002-3628-9390"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210134534","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210134534"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Qiaoshi Lian","raw_affiliation_strings":["NIAID, NIH","1NIAID, NIH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NIAID, NIH","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210134534"]},{"raw_affiliation_string":"1NIAID, NIH","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210134534"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040750947","display_name":"Robert H. Vonderheide","orcid":"https://orcid.org/0000-0002-7252-954X","observed_orcids":["https://orcid.org/0000-0002-7252-954X"]},"institutions":[{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert H Vonderheide","raw_affiliation_strings":["Perelman Sch. of Med., Univ. of Pennsylvania","2Perelman Sch. of Med., Univ. of Pennsylvania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Perelman Sch. of Med., Univ. of Pennsylvania","institution_ids":["https://openalex.org/I79576946"]},{"raw_affiliation_string":"2Perelman Sch. of Med., Univ. of Pennsylvania","institution_ids":["https://openalex.org/I79576946"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088777789","display_name":"Ronald N. Germain","orcid":"https://orcid.org/0000-0003-1495-9143","observed_orcids":["https://orcid.org/0000-0003-1495-9143"]},"institutions":[{"id":"https://openalex.org/I1299303238","display_name":"National Institutes of Health","ror":"https://ror.org/01cwqze88","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238"]},{"id":"https://openalex.org/I4210134534","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1299303238","https://openalex.org/I4210134534"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ronald N Germain","raw_affiliation_strings":["NIAID, NIH","1NIAID, NIH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"NIAID, NIH","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210134534"]},{"raw_affiliation_string":"1NIAID, NIH","institution_ids":["https://openalex.org/I1299303238","https://openalex.org/I4210134534"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111021877","display_name":"Kateyln T Byrne","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]},{"id":"https://openalex.org/I79576946","display_name":"University of Pennsylvania","ror":"https://ror.org/00b30xv10","country_code":"US","type":"education","lineage":["https://openalex.org/I79576946"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kateyln T Byrne","raw_affiliation_strings":["OHSU","Perelman Sch. of Med., Univ. of Pennsylvania","2Perelman Sch. of Med., Univ. of Pennsylvania","3OHSU"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"OHSU","institution_ids":["https://openalex.org/I165690674"]},{"raw_affiliation_string":"Perelman Sch. of Med., Univ. of Pennsylvania","institution_ids":["https://openalex.org/I79576946"]},{"raw_affiliation_string":"2Perelman Sch. of Med., Univ. of Pennsylvania","institution_ids":["https://openalex.org/I79576946"]},{"raw_affiliation_string":"3OHSU","institution_ids":["https://openalex.org/I165690674"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3500,"currency":"USD","value_usd":3500},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"210","issue":"Supplement_1","first_page":"230.11","last_page":"230.11"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.5687999725341797,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10031","display_name":"T-cell and B-cell Immunology","score":0.5687999725341797,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.41190001368522644,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.0019000000320374966,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/anti-cd40-antibody","display_name":"anti-CD40 antibody","score":0.9629999995231628},{"id":"https://openalex.org/keywords/regulatory-t-cells","display_name":"regulatory T cells","score":0.9710000157356262},{"id":"https://openalex.org/keywords/foxp3","display_name":"Foxp3","score":0.5770000219345093},{"id":"https://openalex.org/keywords/pancreatic-ductal-adenocarcinoma","display_name":"pancreatic ductal adenocarcinoma","score":0.8579999804496765},{"id":"https://openalex.org/keywords/tumor-microenvironment","display_name":"tumor microenvironment","score":0.6620000004768372},{"id":"https://openalex.org/keywords/anti-pd-1-antibody","display_name":"anti-PD-1","score":0.734000027179718},{"id":"https://openalex.org/keywords/anti-ctla-4","display_name":"anti-CTLA-4","score":0.9929999709129333},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.7689999938011169},{"id":"https://openalex.org/keywords/mhc-class-ii","display_name":"MHC class II","score":0.6859999895095825},{"id":"https://openalex.org/keywords/il-12","display_name":"IL-12","score":0.9760000109672546},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.8960000276565552},{"id":"https://openalex.org/keywords/batf3","display_name":"Batf3","score":0.8999999761581421},{"id":"https://openalex.org/keywords/tumor-immunosuppression","display_name":"tumor immunosuppression","score":0.6520000100135803}],"concepts":[{"id":"https://openalex.org/C2779727006","wikidata":"https://www.wikidata.org/wiki/Q426188","display_name":"FOXP3","level":3,"score":0.7665892839431763},{"id":"https://openalex.org/C39347974","wikidata":"https://www.wikidata.org/wiki/Q21135811","display_name":"CD40","level":4,"score":0.5853766202926636},{"id":"https://openalex.org/C19106626","wikidata":"https://www.wikidata.org/wiki/Q230749","display_name":"Bystander effect","level":2,"score":0.5588600635528564},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5560706853866577},{"id":"https://openalex.org/C2779234475","wikidata":"https://www.wikidata.org/wiki/Q14897851","display_name":"CD154","level":5,"score":0.504719614982605},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.4815919101238251},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.4588715136051178},{"id":"https://openalex.org/C123982805","wikidata":"https://www.wikidata.org/wiki/Q6046964","display_name":"Interleukin-7 receptor","level":5,"score":0.4127941131591797},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.39851114153862},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.32699888944625854},{"id":"https://openalex.org/C79484868","wikidata":"https://www.wikidata.org/wiki/Q5971673","display_name":"IL-2 receptor","level":4,"score":0.28256240487098694},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.25867679715156555},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.1120445728302002},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.4049/jimmunol.210.supp.230.11","doi":"https://doi.org/10.4049/jimmunol.210.supp.230.11","is_oa":true,"landing_page_url":"https://doi.org/10.4049/jimmunol.210.supp.230.11","pdf_url":"https://journals.aai.org/jimmunol/article-pdf/210/1_Supplement/230.11/1631010/230_11.pdf","source":{"id":"https://openalex.org/S38008053","display_name":"The Journal of Immunology","issn_l":"0022-1767","issn":["0022-1767","1550-6606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4320800377","host_organization_name":"American Association of Immunologists","host_organization_lineage":["https://openalex.org/P4320800377"],"host_organization_lineage_names":["American Association of Immunologists"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Immunology","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.4049/jimmunol.210.supp.230.11","doi":"https://doi.org/10.4049/jimmunol.210.supp.230.11","is_oa":true,"landing_page_url":"https://doi.org/10.4049/jimmunol.210.supp.230.11","pdf_url":"https://journals.aai.org/jimmunol/article-pdf/210/1_Supplement/230.11/1631010/230_11.pdf","source":{"id":"https://openalex.org/S38008053","display_name":"The Journal of Immunology","issn_l":"0022-1767","issn":["0022-1767","1550-6606"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-2","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4320800377","host_organization_name":"American Association of Immunologists","host_organization_lineage":["https://openalex.org/P4320800377"],"host_organization_lineage_names":["American Association of Immunologists"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Immunology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4385686241.pdf","grobid_xml":"https://content.openalex.org/works/W4385686241.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4306939825","https://openalex.org/W7148383868","https://openalex.org/W4362593426","https://openalex.org/W2736312236","https://openalex.org/W4313408154","https://openalex.org/W4408362108","https://openalex.org/W2547388862","https://openalex.org/W4393087222","https://openalex.org/W4404513400","https://openalex.org/W7164144717"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"Pancreatic":[2],"ductal":[3],"adenocarcinoma":[4],"(PDA)":[5],"is":[6,13,39],"an":[7,70,245],"aggressive":[8],"and":[9,27,67,74,163,165,183,280],"heterogeneous":[10],"cancer":[11],"that":[12,21,49,103,144],"often":[14],"refractory":[15],"to":[16,40,59,94,107,115,132,138,192,244,283],"current":[17],"treatments.":[18],"We":[19,89,125],"found":[20,90,143],"a":[22,99,223],"combination":[23,184],"of":[24,36,63,79,146,161,168,176,189,198,241,261,271],"anti-PD1,":[25],"anti-CTLA-4,":[26],"anti-CD40":[28,123,190,232],"results":[29],"in":[30,69,180,186],"tumor":[31,117,204,250],"regression.":[32],"Thus,":[33],"the":[34,61,77,116,147,187,228,234,239,249],"aim":[35],"our":[37,82],"study":[38],"gain":[41],"mechanistic":[42],"understanding":[43],"into":[44,206],"this":[45,91,194,217],"therapeutic":[46],"combination.":[47],"To":[48],"end,":[50],"we":[51,142],"leverage":[52],"quantitative":[53],"high":[54,159],"multiplex":[55],"microscopy,":[56],"enabling":[57],"us":[58],"decipher":[60],"complexities":[62],"cellular":[64],"behaviors,":[65],"interactions,":[66],"phenotypes":[68],"intact":[71],"TME.":[72],"Results":[73],"Conclusions":[75],"In":[76],"TME":[78],"responsive":[80],"tumors,":[81],"therapy":[83,139],"severely":[84],"depleted":[85],"regulatory":[86],"T":[87],"cells.":[88],"Treg":[92,109],"loss":[93],"be":[95],"ADCC\u2013independent,":[96],"but":[97],"anti-CD40\u2013dependent,":[98],"surprising":[100],"result":[101],"given":[102],"anti-CTLA-4":[104],"was":[105,254],"thought":[106],"mediate":[108],"depletion.":[110],"Residual":[111],"Tregs":[112,150,243],"were":[113],"restricted":[114],"periphery":[118],"by":[119,226,256],"48":[120],"hours":[121],"post":[122],"administration.":[124],"used":[126],"tamoxifen-inducible":[127],"Foxp3":[128],"lineage":[129,148],"tracing":[130],"mice":[131,214],"label":[133],"all":[134],"Foxp3\u2013expressing":[135],"cells":[136],"prior":[137],"initiation.":[140],"Strikingly,":[141],"many":[145],"marked":[149],"no":[151],"longer":[152],"expressed":[153],"Foxp3.":[154],"These":[155],"ExTregs":[156],"now":[157],"had":[158,166],"levels":[160],"Tbet":[162],"IFNg,":[164],"evidence":[167],"cognate":[169],"antigen":[170],"recognition,":[171],"as":[172],"assessed":[173],"via":[174],"imaging":[175],"NFAT1":[177],"nuclear":[178],"translocation":[179],"situ.":[181],"Single":[182],"treatments":[185],"absence":[188],"failed":[191],"induce":[193],"ExTreg":[195],"phenomenon.":[196,218],"Blockade":[197],"MHC-II,":[199],"IL-12,":[200],"or":[201,203,211],"IFNg":[202,212],"implantation":[205],"Batf3":[207],"KO,":[208,210],"IL12p40":[209],"KO":[213],"also":[215],"ablated":[216],"Combined,":[219],"these":[220],"data":[221],"reveal":[222],"unique":[224],"mechanism":[225],"which":[227],"clinically":[229],"relevant":[230],"agonistic":[231],"amplifies":[233],"anti-tumor":[235],"immune":[236],"compartment":[237],"through":[238],"conversion":[240],"immunosuppressive":[242],"effector":[246],"population":[247],"within":[248],"microenvironment.":[251],"This":[252],"work":[253],"supported":[255],"(1)":[257],"Intramural":[258],"Research":[259,266],"Program":[260],"NIAID,":[262],"NIH,":[263,273],"(2)":[264],"Postdoctoral":[265],"Associate":[267],"Training":[268],"(PRAT)":[269],"Fellowship":[270],"NIGMS,":[272],"(3)":[274],"Parker":[275],"Institute":[276],"for":[277],"Cancer":[278],"Immunotherapy,":[279],"(4)":[281],"Bench":[282],"Bedside":[284],"Award.":[285]},"counts_by_year":[],"updated_date":"2026-10-14T16:39:01.820549","created_date":"2023-08-10T00:00:00"}